id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2007-D-0433-0009,FDA,FDA-2007-D-0433,Draft Guidances for Industry; Bioequivalence Recommendation for Lenalidomide Capsules,Other,Guidance,2012-11-06T05:00:00Z,2012,11,2012-11-06T05:00:00Z,,2024-11-11T20:43:53Z,,1,0,090000648115f67b
FDA-2007-D-0433-0008,FDA,FDA-2007-D-0433,Draft Guidances for Industry; Availability: Bioequivalence Recommendation for Lenalidomide Capsules,Notice,Notice of Availability,2012-11-06T05:00:00Z,2012,11,2012-11-06T05:00:00Z,2013-01-08T04:59:59Z,2013-01-08T03:27:42Z,2012-27004,0,0,090000648115f3c3